stethoscope

Join our network and find credentialing information.

Log in to Availity Essentials™ to access patient benefits, claims information and more.

Find tools and materials to support doing business with us.

Learn more about research and trends that impact your practice.

Find self-service info and phone numbers and update your provider data.

Review prior authorization lists for services, medications and submission guidance.

Prior authorization submission information

Professionally administered drugs prior authorization

Find appeals guidelines and payment policy information.

Learn how to submit claims and find coding guidance.

Find policies for procedures, devices and medications.

Review guidelines and health programs to support your patients and practice.

Find dental benefits, tools and resources.

Prior authorization for professionally administered drugs 

Locate state-specific resources for Humana Healthy Horizons® (Medicaid).

compass

Shop plans, learn about Medicare and explore member resources.

Search for in-network medical, vision, dental and pharmacy providers.

Transplant and Specialty Services Network Guidelines 

Humana’s National Transplant and Specialty Services Network consists of solid organ transplants, stem cell transplants, Chimeric antigen receptor (CAR) T-cell therapy, gene therapy, Ventricular Assist Devices (VAD) and VAD supplies.  

To participate in Humana’s National Transplant and Specialty Services Network for solid organ transplants, a transplant center must be a CMS (Centers for Medicare and Medicaid Services) approved center for the specific transplant program. Also, the center must have active Organ Procurement and Transplantation Network (OPTN) membership. Both CMS and OPTN have requirements that centers must meet, such as transplant volume, graft/patient survival and other pertinent facility statistical data from the Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network.   

For Stem Cell transplants, the facility must be FACT (Foundation for the Accreditation of Cellular Therapy) accredited. FACT has a set of requirements to ensure patient safety and outcomes, such as volume of allogeneic stem cell transplants and patient survival reported by Center for International Blood & Marrow Transplant Research (CIBMTR).   

All CAR-T and gene therapy drugs must be approved by the Food and Drug Administration (FDA).   

A list of Transplant and Specialty Services Network Centers/Suppliers can be found here: National Transplant Network Locator - Humana 

Patient care